• Nenhum resultado encontrado

Delayed Huntington's disease diagnosis in two alcoholic patients with a family history of

N/A
N/A
Protected

Academic year: 2018

Share "Delayed Huntington's disease diagnosis in two alcoholic patients with a family history of"

Copied!
1
0
0

Texto

(1)

Delayed Huntington’s

Disease Diagnosis in Two

Alcoholic Patients With a

Family History of

“Parkinson’s Disease”

To the Editor:Huntington’s disease is

an autosomal dominant neurodegen-erative disease characterized by a triad of symptoms and signs includ-ing movement disorder, cognitive impairment, and behavioral syn-dromes.1As the earliest pathological changes in Huntington’s disease are in the associative portion of the stria-tum, the domains first affected by the disease may be cognitive and psychiatric rather than motor.2,3

Case Report

A 51-year-old woman with a his-tory of alcohol abuse, though absti-nent for 3 years, presented with cognitive deterioration. She could no longer teach properly because she forgot what to say, was unable to repeat information, could no longer handle money, and didn't know how to cook or take care of the house. On one occasion she tried to spice the salad with liquid soap and put the mobile phone in the refrigerator. She also com-plained of irritability, aggressive outbursts, sadness, anxiety, rest-lessness, and hyperphagia with a preference for sweet foods. These symptoms evolved over the last 10 years. In the previous 3 years, after being hospitalized for alcohol detoxification, she started noticing unsteady gait with frequent falls and involuntary movements, espe-cially in her lower limbs, which would frequently kick even when she was lying down.

Her family history included what was called “Parkinson’s disease” in her mother, grandmother and two maternal uncles. The patient also had a 52-year-old sister who was receiving psychiatric treatment for alcohol abuse and depressive syn-drome and who had recent pre-sented behavioral changes includ-ing agitation, anxiety, overactivity, and frequent falls.

Neurological examination of the patient showed severe akathisia with noticeable lower-limb predominant choreiform movements and discrete motor perseveration. Her Mini-Men-tal State Examination score was 23.

An analytic study, including CBC, vitamin B12and folic acid levels,

thy-roid, and hepatic functions revealed no abnormalities in our patient. A brain MRI showed generalized brain atrophy especially in the frontal lobe. Neuropsychological study revealed dementia in an early stage with fron-totemporal characteristics. Genetic testing for Huntington’s disease was positive, as it was also positive for our patient’s oldest sister. The patient’s daughter decided to do the presymptomatic test for Hunting-ton’s disease and had also the abnor-mal expansion in the gene.

Discussion

Glutamate excitotoxicity has been implicated in the pathophysiology of movement disorder and other manifestations of Huntington’s dis-ease. Alcohol has been shown to inhibit NMDA receptors in rats and mice as well as to retard pro-gression of Huntington’s disease disorder in humans.4Chronic NMDA inhibition has also been reported to lead to NMDA upregu-lation, increasing the risk of gluta-mate excitotoxicity.4Thus, alcohol

intake may initially inhibit NMDA receptors and mask Huntington’s disease manifestations, but chronic alcohol use may lead to receptor upregulation, resulting in NMDA excitotoxicity and manifestation of Huntington’s disease.4

Huntington’s disease patients can present with rigidity without signs of chorea. Such individuals can be misdiagnosed with Parkinson’s dis-ease, catatonia, or schizophrenia.5 This might have been the case with this patient’s mother and grand-mother, both of whom died with cognitive deterioration and move-ment abnormalities.

This case highlights the impor-tance of a careful family history, as the presence of disease in multiple members of the same family can be a fundamental clue for a genetic cause and help to make the correct diagnosis.

Joana Mesquita, M.D. Lui´sa Silva, M.D.

Psychiatry and Mental Health Department, Hospital de Sa˜o Marcos, Braga, Portugal A´lvaro Machado, M.D.

Neurology Department, Hospital de Sa˜o Marcos, Braga, Portugal

References

1. Anderson KE, Marder KS: An overview of psychiatric symptoms in Huntington’s dis-ease. Curr Psychiatr Rep 2001; 3:379–388 2. Paulsen JS, Ready RE, Hamilton JM, et al: Neuropsychiatric aspects of Hunting-ton’s disease. J Neurol Neurosurg Psy-chiatry 2001; 71:310 –314

3. Duijn EV, Kingma EM, Mast RC: Psycho-pathology in verified Huntington’s dis-ease gene carriers. J Neuropsychiatry Clin Neurosci 2007; 19:441– 447

4. Matoo SK, Khurana H: Huntington's dis-ease and alcohol abuse. Neurol India 1999; 47:68 –70

5. Walker FO: Huntington's disease. Lancet 2007; 369:218 –228

LETTERS

Referências

Documentos relacionados

A busca de uma autonomia no mundo das produções artísticas é um longo caminho construído historicamente: a edificação de um espaço próprio para a arte, galgado

RNAi Center (VDRC). Schematic representation of the effects of MGO glycation in models of HD. Glycation increases HTT intracellular levels and inclusion formation in yeast and

(1977), quando encontraram, para a mesma espécie e no mesmo pomar, dois picos, ha- vendo um afastamento quanto ao acme, pois este ocorreu no mês de janeiro. 2) se aproxi- ma

The ConfigurationGenerator method has the expertons lists and the respective KPIs, and the definition of the cost function as its inputs, and delivers the configurations list and

Com intuito de comprovar e explicar o efeito da matéria orgânica e alada compará-lo com outros meios de eliminação da toxidez de manganês, incluiu-se os seguintes tratamentos

Por sua vez, a base de dados foi criada à semelhança da estrutura da base de dados interna da aplicação A minha Diabetes, sendo que os dados armazenados consistiam em registos

Pregnancy is a unique state for women, offering an opportunity for diagnosis of kidney disease, but also a state in which acute and chronic kidney diseases may manifest, and which

As no previous information for binding residues of NMDAR in humans was reported, the binding site was retrieved by using the binding site resi- dues of NMDAR reported in the